Complement resistance of tumor cells: basal and induced mechanisms. (Q33852679)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Complement resistance of tumor cells: basal and induced mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author

Helena García Schüler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Jurianz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Ziegler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Kraus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

O Bohana-Kashtan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Z Fishelson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Kirschfink

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

13-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

929-939

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Autoantibody-mediated acquired deficiency of C1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Differential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Complement-regulatory proteins in ovarian malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

The influence of tumour necrosis factor-alpha, interleukin-1 beta and interferon-gamma on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Down-regulation of CD59 (protectin) expression on human colorectal adenocarcinoma cell lines by levamisole

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Expression and function of CD59 on colonic adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Enhanced sensitivity of P‐glycoprotein‐positive multidrug resistant tumor cells to complement‐mediated lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Rapid increase in intracellular free Ca2+ induced by antibody plus complement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Experimental tumoricidal effects of monoclonal antibody against solid breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Identification of p-57, a serine proteinase, from human erythrocyte membranes, which cleaves both chains of human third component (C3) of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

The human lymphokine leukoregulin induces cell resistance to complement-mediated lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Pre-operative plasma levels of C-reactive protein, albumin and various plasma protease inhibitors for the pre-operative assessment of operability and recurrence in cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Extracellular ATP: effects, sources and fate

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Tumour cell killing using chemically engineered antibody constructs specific for tumour cells and the complement inhibitor CD59

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Leishmanial protein kinases phosphorylate components of the complement system.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Expression and function of the complement membrane attack complex inhibitor protectin (CD59) in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: amino-acid-sequence identities with procathepsin L

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Neutralization of complement regulatory proteins augments lysis of breast carcinoma cells targeted with rhumAb anti-HER2

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding proteindependent cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Phosphorylation of the complement component, C9, by an ecto-protein kinase of human leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Shedding of tyrosine and serine/threonine ecto-protein kinases from human leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Sublytic complement attack protects tumor cells from lytic doses of antibody and complement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Complement membrane attack complexes induce in human leukemic cells rapid expression of large proteins (L-CIP).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Membrane-associated cathepsin L: a role in metastasis of melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Soluble complement receptor 1 is increased in patients with leukemia and after administration of granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Enhanced glomerular prostaglandin formation in experimental membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

A mechanism for the insertion of complement component C9 into target membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistanc

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Relative contributions of decay accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 in the protection of melanocytes from homologous complement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

The multidrug resistance phenotype confers immunological resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Intracellular pH and multidrug resistance regulate complement-mediated cytotoxicity of nucleated human cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Fish oil has protective and therapeutic effects on proteinuria in passive Heymann nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Protection of thyroid cancer cells by complement-regulatory factors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

Homologous restriction of complement-mediated cell lysis can be markedly enhanced by blocking decay-accelerating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2899%2900115-7

7 January 2021

10.1016/S0161-5890(99)00115-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10698347%20AND%20SRC:MED&resulttype=core&format=json